GeneDx Holdings Corp vs Utilities Select Sector SPDR Fund — how do they compare? GeneDx Holdings Corp trades at $86.53 (market cap $2.58B), while Utilities Select Sector SPDR Fund trades at $43.21. The key difference: GeneDx Holdings Corp is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| WGS | XLU | |
|---|---|---|
Market Cap | $2.58B | — |
Sector | Technology | — |
52-Week High | $167.51 | $47.73 |
52-Week Low | $34.51 | $41.86 |
Enterprise Value | $2.61B | — |
Signals from Pluang's Aura AI — not financial advice
WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.
Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.
XLU trades at $43.45, up 0.86% with a bullish technical signal despite bearish moving averages. The utilities ETF shows neutral oscillators with RSI at 57.53, trading near key support at $43. Recent news highlights XLU's defensive positioning amid market volatility and AI power demand growth, though some analysts question its AI exposure concentration.
Outlook remains cautiously optimistic as utilities benefit from AI-driven power demand and defensive characteristics during economic uncertainty. Key risks include regulatory changes affecting data-center growth and interest rate sensitivity. The sector's stable dividend profile provides income support while growth potential depends on AI infrastructure expansion.
Trailing returns across standard periods
Latest headlines on both assets
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →